# Analyzing Free Cash Flow Metrics for Cannabis Strategic Ventures > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/cannabis-company-financial-metrics-free-cash-flow/ > **Published:** 2026-04-11T23:02:10-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T17:06:12-04:00 > **Clinical Summary:** Explore cannabis company financial metrics focusing on free cash flow per share for Cannabis Strategic Ventures and its investment implications. --- ✦ New CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic IndustryInvestmentNon-ClinicalFinancial Why This Matters This financial metric for a cannabis company has no direct clinical relevance to patient care or [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) practice. Financial performance of individual cannabis companies does not inform treatment decisions or clinical outcomes. Clinical Summary Free cash flow per share is a financial metric measuring a company’s cash generation relative to outstanding shares. This particular metric relates to Cannabis Strategic Ventures, a publicly traded cannabis company. No clinical data, therapeutic outcomes, or patient safety information is presented in this financial reporting. Dr. Caplan’s Take “I focus on clinical evidence and patient outcomes, not stock performance. A company’s financial metrics tell us nothing about the safety or efficacy of [cannabis as medicine](https://cedclinic.com/cannabinoids-in-reward-processing-pain-perception/).” Clinical Perspective 🧠 Clinicians should distinguish between [cannabis industry](https://cedclinic.com/cannabis-mold-contamination-risks-recall-safety/) financial news and actual [clinical research](https://cedclinic.com/cannabis-based-therapies-smoking-cessation/). Investment performance does not correlate with therapeutic value or safety profiles of cannabis products. Clinical decisions should be based on peer-reviewed research and patient-specific factors, not market metrics. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Free%20cash%20flow%20per%20share%20of%20Cannabis%20Strategic%20Ventures%20%E2%80%93%20OTC%3ANUGS%20-%20TradingView%20%40drcaplan&url=https%3A//www.tradingview.com/symbols/OTC-NUGS/financials-statistics-and-ratios/free-cash-flow-per-share/)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//www.tradingview.com/symbols/OTC-NUGS/financials-statistics-and-ratios/free-cash-flow-per-share/)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Free%20cash%20flow%20per%20share%20of%20Cannabis%20Strategic%20Ventures%20%E2%80%93%20OTC%3ANUGS%20-%20TradingView%20--%20via%20%40drcaplan.bsky.social%20https%3A//www.tradingview.com/symbols/OTC-NUGS/financials-statistics-and-ratios/free-cash-flow-per-share/)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://www.tradingview.com/symbols/OTC-NUGS/financials-statistics-and-ratios/free-cash-flow-per-share/](https://www.tradingview.com/symbols/OTC-NUGS/financials-statistics-and-ratios/free-cash-flow-per-share/) – The complete article headline – The full article body text – Key details about the cannabis industry/investment news being reported [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [IM Cannabis posts C$54.7M revenue, positive cash flow | IMCC Stock News](https://cedclinic.com/im-cannabis-revenue-report-c-54-7m-positive-cash-flow/) Review IM Cannabis's recent financial results highlighting revenue growth and positive cash flow performance. [Read More](https://cedclinic.com/im-cannabis-revenue-report-c-54-7m-positive-cash-flow/) Financial Research Associate Salaries in the United States for Cannabis Employment Professionals Explore salary trends and financial roles within the [cannabis industry](https://cedclinic.com/cannabis-mold-contamination-risks-recall-safety/) workforce. Explore Salaries [MJNA Stock Symbol: A Guide to Medical Marijuana, Inc. – Bitget](https://cedclinic.com/medical-marijuana-stock-analysis-mjna-guide-bitget/) A comprehensive guide to [Medical Marijuana](https://cedclinic.com/cannabis-cardiovascular-risk-impact/), Inc.'s stock symbol and investment overview. [Learn More](https://cedclinic.com/medical-marijuana-stock-analysis-mjna-guide-bitget/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).